News
Surgery, not antibiotics, might be the best way to treat chronic rhinosinusitis, a condition that leaves people with a permanently blocked or runny nose and a reduced sense of smell ...
Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved standardization of care, ...
Chronic obstructive pulmonary disease, or COPD, is a group of lung diseases with no cure. CNN wellness expert Dr. Leana Wen ...
A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and the UCLA Palliative Care Research Center, found that many people with advanced cancer report that their ...
A risk assessment tool including five factors identified whether patients with chronic lung disease and pulmonary ...
Hard-to-get insurance, high costs, and limited treatment access are key barriers to care for COPD patients in the U.S., a new ...
3d
TipRanks on MSNAstraZeneca’s PRESTO Study: A New Hope for COPD Treatment?
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a study titled A Multicentre, ...
A 68-year-old man with severe PAH and multiple coexisting conditions experienced marked improvement after receiving ...
Prioritizing communications between patients and health care providers and increasing patient education about chronic ...
7d
TipRanks on MSNRegeneron and Sanofi’s Itepekimab Study: A Potential Game-Changer for COPD Treatment
The recent clinical study update from Regeneron Pharmaceuticals and Sanofi focuses on the investigation of Itepekimab, an anti-IL-33 monoclonal antibody, to understand its effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results